Reactive atrial-based antitachycardia pacing therapy reduces atrial tachyarrhythmias.

George H CrossleyLuigi PadelettiSteven L ZweibelJ Harrison HudnallYan ZhangGiuseppe Boriani

Published in: Pacing and clinical electrophysiology : PACE (2019)

Among real-world patients from a large device database, rATP therapy was significantly associated with a reduced risk of AT/AF. This association was independent of whether the patient had a pacemaker, defibrillator, or resynchronization device.

Keyphrases

atrial fibrillation
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
left atrial
cardiac resynchronization therapy
case report
peritoneal dialysis
prognostic factors
heart failure
mesenchymal stem cells
adverse drug
pulmonary embolism
electronic health record